Manila distributes 622 vials of tocilizumab for COVID-19 patients nationwide | Inquirer News

Manila distributes 622 vials of tocilizumab for COVID-19 patients nationwide

By: - Reporter / @zacariansINQ
/ 01:04 AM September 15, 2021

MANILA, Philippines — Manila has distributed 622 vials of anti-inflammatory drug tocilizumab to parts of Luzon, the Visayas, and Mindanao for use on patients with severe or critical COVID-19, according to a statement issued on Tuesday by the city’s Public Information Office.

The vials were given to 12 cities in Metro Manila, 17 areas in Luzon, three in the Visayas, and three in Mindanao.

The Department of Health (DOH) is currently struggling to procure tocilizumab, which is currently in short supply.

ADVERTISEMENT

Undersecretary Maria Rosario Vergeire, the spokesperson of the DOH, said the health had started coordinating with various suppliers of the tocilizumab, such as Switzerland and Iran.

READ: DOH scrambles for supply of COVID drugs

Manila Mayor Francisco “Isko Moreno” Domagoso himself earlier urged the national government to focus funds on the procurement of COVID-19 drugs, like tocilizumab and remdesivir, instead of face shields — especially amid the recent surge of COVID-19 cases caused by the more transmissible Delta variant.

READ: Isko urges gov’t: Instead of face shields, buy tocilizumab and remdesivir

As of Tuesday, Sept. 14, the Philippines had a total of  2,266,066 COVID-19 cases, which includes 177,670 active infections, 2,052,867 recoveries, and 35,529 deaths.

Meanwhile, Metro Manila and 11 other regions have been classified as high risk for COVID-19. The other areas are the Cordillera Administrative Region, Calabarzon, Cagayan Valley, Central Luzon, Davao Region, Ilocos Region, Northern Mindanao, Caraga, Western Visayas, Soccsksargen, and Zamboanga Peninsula.

ADVERTISEMENT

RELATED STORIES

COVID drug supplies running low, says DOH 

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

NKTI suspends dispensing of remdesivir, tocilizumab due to critical supply 

FDA asks tocilizumab maker for more supply

atm

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Manila, pandemic, tocilizumab 

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.